NCT01764204已完成不适用
Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30,840
- 试验地点
- 48
- 主要终点
- incidence of severe adverse drug reactions
研究概览
简要总结
To highlight the incidence of adverse reactions of Qingkailing Injection.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Year 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
- •in accordance with ethics requirements.
排除标准
- 未提供
研究组 & 干预措施
Qingkailing Injection
干预措施: Qingkailing Injection (Drug)
结局指标
主要结局
incidence of severe adverse drug reactions
时间窗: 2 years
次要结局
- incidence of adverse drug reactions(2 years)
研究者
Zhong Wang
Professor
China Academy of Chinese Medical Sciences
研究点 (48)
Loading locations...
相似试验
已完成
不适用
Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)Essential HypertensionNCT02385721Boryung Pharmaceutical Co., Ltd601
撤回
不适用
A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) TreatmentThrombosis, Deep VeinPulmonary EmbolismNCT03812835Pfizer
已完成
不适用
Study Evaluating Pharmacovigilance Of Refacto AFHemophilia ANCT00895037Pfizer101
已完成
不适用
The Effect of Medication Review in High-risk Emergency Department PatientsAdverse Drug EventsAdverse Drug ReactionsMedication-related ProblemsNCT02122965University of British Columbia10,805
已完成
不适用
adverse drug reactions and quality of life with anti-hiv treatmentCTRI/2019/02/017398Dr Ruchika Irene Dillu100